Key Highlights in interstitial lung disease (ILD): Insights from ATS 2025
Learning objectives:
- Understand the key highlights and latest advancements in ILD presented at ATS 2025.
- Review and interpret the outcome and key data from ILD trials presented at ATS 2025.
- Assess the clinical relevance and potential impact of these findings on patient care.
Program date: June 4, 2025
Speaker: Dr. Martin Kolb, MD PhD
Professor
Director Division of respirology
McMaster University
Speaker: Dr. Bohyung Min, MD, FRCPC
Clinical Lecturer, University of Calgary
Moderator: Dr. Kerri Johannson, MD, MPH, FRCPC ATSF
Respirologist
Associate Professor, Department of Medicine
Snyder Institute for Chronic Diseases
University of Alberta
Questions?
The presenters are solely responsible for developing the content of this presentation and maintaining scientific accuracy, objectivity, and balance. Any discussions of clinical practice or treatment represent the opinions of the presenter alone. This video is made available for attendees, registrants, and individuals requesting further information on this learning program.